{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T09:00:50Z","timestamp":1780131650793,"version":"3.54.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008608","name":"Sumitomo Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018326","name":"Suntory Foundation for Life Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007533","name":"Kobayashi Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007533","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007428","name":"Naito Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008886","name":"Princess Takamatsu Cancer Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008886","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Astellas Foundation for Reseach on Metabolic Disorders"},{"DOI":"10.13039\/501100006062","name":"Foundation for Promotion of Cancer Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006062","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100001009","name":"Bristol Myers Squibb Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001009","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Cancer Center Research, Development Fund"},{"name":"JST SPRING"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Mol Morphol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00795-026-00456-4","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T06:54:14Z","timestamp":1770792854000},"page":"134-145","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comprehensive analysis of DNA repair, morphological remodeling and immune-gene expression in patient-derived biliary tract carcinoma organoids following ionizing radiation"],"prefix":"10.1007","volume":"59","author":[{"given":"Ken","family":"Okuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunji","family":"Haruna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihide","family":"Muramatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Tateno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayu","family":"Isono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiro","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Oike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruka","family":"Okami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiko","family":"Yokobori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimasa","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8912-6977","authenticated-orcid":false,"given":"Atsushi","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,11]]},"reference":[{"key":"456_CR1","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","volume":"383","author":"N Razumilava","year":"2014","unstructured":"Razumilava N, Gores GJ (2014) Cholangiocarcinoma. Lancet 383:2168\u20132179","journal-title":"Lancet"},{"key":"456_CR2","doi-asserted-by":"crossref","unstructured":"Razumilava N, Gores GJ. Classification, diagnosis, and management of cholangiocarcinoma. Clin Gastroenterol Hepatol. 2013; 11: 13\u201321.e11; quiz e13\u201314.","DOI":"10.1016\/j.cgh.2012.09.009"},{"key":"456_CR3","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1053\/j.gastro.2013.10.013","volume":"145","author":"SI Ilyas","year":"2013","unstructured":"Ilyas SI, Gores GJ (2013) Pathogenesis, diagnosis, and management of cholangiocarcinoma. Gastroenterology 145:1215\u20131229","journal-title":"Gastroenterology"},{"key":"456_CR4","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1053\/j.gastro.2009.02.038","volume":"136","author":"JE Everhart","year":"2009","unstructured":"Everhart JE, Ruhl CE (2009) Burden of digestive diseases in the United States Part III: liver, biliary tract, and pancreas. Gastroenterology 136:1134\u20131144","journal-title":"Gastroenterology"},{"key":"456_CR5","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S1470-2045(20)30109-1","volume":"21","author":"GK Abou-Alfa","year":"2020","unstructured":"Abou-Alfa GK, Sahai V, Hollebecque A et al (2020) Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study. Lancet Oncol 21:671\u2013684","journal-title":"Lancet Oncol"},{"key":"456_CR6","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/S1470-2045(20)30157-1","volume":"21","author":"GK Abou-Alfa","year":"2020","unstructured":"Abou-Alfa GK, Macarulla T, Javle MM et al (2020) Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study. Lancet Oncol 21:796\u2013807","journal-title":"Lancet Oncol"},{"key":"456_CR7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nri.2016.107","volume":"17","author":"L Galluzzi","year":"2017","unstructured":"Galluzzi L, Buqu\u00e9 A, Kepp O, Zitvogel L, Kroemer G (2017) Immunogenic cell death in cancer and infectious disease. Nat Rev Immunol 17:97\u2013111","journal-title":"Nat Rev Immunol"},{"key":"456_CR8","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1084\/jem.20052494","volume":"203","author":"EA Reits","year":"2006","unstructured":"Reits EA, Hodge JW, Herberts CA et al (2006) Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy. J Exp Med 203:1259\u20131271","journal-title":"J Exp Med"},{"key":"456_CR9","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1056\/NEJMoa1709937","volume":"377","author":"SJ Antonia","year":"2017","unstructured":"Antonia SJ, Villegas A, Daniel D et al (2017) Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer. N Engl J Med 377:1919\u20131929","journal-title":"N Engl J Med"},{"key":"456_CR10","doi-asserted-by":"publisher","first-page":"e1442166","DOI":"10.1080\/2162402X.2018.1442166","volume":"7","author":"A Roger","year":"2018","unstructured":"Roger A, Finet A, Boru B et al (2018) Efficacy of combined hypo-fractionated radiotherapy and anti-PD-1 monotherapy in difficult-to-treat advanced melanoma patients. Oncoimmunology 7:e1442166","journal-title":"Oncoimmunology"},{"key":"456_CR11","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1667\/RR15048.1","volume":"190","author":"Q Qin","year":"2018","unstructured":"Qin Q, Nan X, Miller T et al (2018) Complete local and abscopal responses from a combination of radiation and Nivolumab in refractory Hodgkin\u2019s lymphoma. Radiat Res 190:322\u2013329","journal-title":"Radiat Res"},{"key":"456_CR12","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.immuni.2011.05.003","volume":"34","author":"YM Loo","year":"2011","unstructured":"Loo YM, Gale M Jr. (2011) Immune signaling by RIG-I-like receptors. Immunity 34:680\u2013692","journal-title":"Immunity"},{"key":"456_CR13","doi-asserted-by":"publisher","first-page":"e104036","DOI":"10.15252\/embj.2019104036","volume":"39","author":"X Feng","year":"2020","unstructured":"Feng X, Tubbs A, Zhang C et al (2020) ATR inhibition potentiates ionizing radiation-induced interferon response via cytosolic nucleic acid-sensing pathways. EMBO J 39:e104036","journal-title":"EMBO J"},{"key":"456_CR14","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41577-021-00524-z","volume":"21","author":"A Decout","year":"2021","unstructured":"Decout A, Katz JD, Venkatraman S, Ablasser A (2021) The cGAS-STING pathway as a therapeutic target in inflammatory diseases. Nat Rev Immunol 21:548\u2013569","journal-title":"Nat Rev Immunol"},{"key":"456_CR15","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/nature23449","volume":"548","author":"KJ Mackenzie","year":"2017","unstructured":"Mackenzie KJ, Carroll P, Martin CA et al (2017) cGAS surveillance of micronuclei links genome instability to innate immunity. Nature 548:461\u2013465","journal-title":"Nature"},{"key":"456_CR16","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/nature23470","volume":"548","author":"SM Harding","year":"2017","unstructured":"Harding SM, Benci JL, Irianto J, Discher DE, Minn AJ, Greenberg RA (2017) Mitotic progression following DNA damage enables pattern recognition within micronuclei. Nature 548:466\u2013470","journal-title":"Nature"},{"key":"456_CR17","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1080\/15384047.2020.1834792","volume":"22","author":"Q Zhao","year":"2021","unstructured":"Zhao Q, Chen Y, Du S et al (2021) Integration of radiotherapy with anti-PD-1 antibody for the treatment of intrahepatic or hilar cholangiocarcinoma: reflection from four cases. Cancer Biol Ther 22:175\u2013183","journal-title":"Cancer Biol Ther"},{"key":"456_CR18","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s40425-019-0692-z","volume":"7","author":"X Liu","year":"2019","unstructured":"Liu X, Yao J, Song L, Zhang S, Huang T, Li Y (2019) Local and abscopal responses in advanced intrahepatic cholangiocarcinoma with low TMB, MSS, pMMR and negative PD-L1 expression following combined therapy of SBRT with PD-1 blockade. J Immunother Cancer 7:204","journal-title":"J Immunother Cancer"},{"key":"456_CR19","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nrc.2018.6","volume":"18","author":"W Ngwa","year":"2018","unstructured":"Ngwa W, Irabor OC, Schoenfeld JD, Hesser J, Demaria S, Formenti SC (2018) Using immunotherapy to boost the abscopal effect. Nat Rev Cancer 18:313\u2013322","journal-title":"Nat Rev Cancer"},{"key":"456_CR20","doi-asserted-by":"publisher","first-page":"100009","DOI":"10.1016\/j.xpro.2019.100009","volume":"1","author":"Y Saito","year":"2020","unstructured":"Saito Y, Muramatsu T, Saito H (2020) Establishment and long-term culture of organoids derived from human biliary tract carcinoma. STAR Protoc 1:100009","journal-title":"STAR Protoc"},{"key":"456_CR21","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/1471-2105-14-219","volume":"14","author":"J Sun","year":"2013","unstructured":"Sun J, Nishiyama T, Shimizu K, Kadota K (2013) TCC: an R package for comparing tag count data with robust normalization strategies. BMC Bioinformatics 14:219","journal-title":"BMC Bioinformatics"},{"key":"456_CR22","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/nprot.2009.97","volume":"4","author":"S Durinck","year":"2009","unstructured":"Durinck S, Spellman PT, Birney E, Huber W (2009) Mapping identifiers for the integration of genomic datasets with the R\/Bioconductor package biomaRt. Nat Protoc 4:1184\u20131191","journal-title":"Nat Protoc"},{"key":"456_CR23","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.jhep.2005.09.025","volume":"44","author":"Y Zen","year":"2006","unstructured":"Zen Y, Sasaki M, Fujii T et al (2006) Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct--an immunohistochemical study of 110 cases of hepatolithiasis. J Hepatol 44:350\u2013358","journal-title":"J Hepatol"},{"key":"456_CR24","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.celrep.2019.03.088","volume":"27","author":"Y Saito","year":"2019","unstructured":"Saito Y, Muramatsu T, Kanai Y et al (2019) Establishment of Patient-Derived Organoids and Drug Screening for Biliary Tract Carcinoma. Cell Rep 27:1265-1276.e1264","journal-title":"Cell Rep"},{"key":"456_CR25","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1097\/00000478-200006000-00014","volume":"24","author":"A Rullier","year":"2000","unstructured":"Rullier A, Le Bail B, Fawaz R, Blanc JF, Saric J, Bioulac-Sage P (2000) Cytokeratin 7 and 20 expression in cholangiocarcinomas varies along the biliary tract but still differs from that in colorectal carcinoma metastasis. Am J Surg Pathol 24:870\u2013876","journal-title":"Am J Surg Pathol"},{"key":"456_CR26","doi-asserted-by":"publisher","first-page":"5120","DOI":"10.1038\/s41467-020-18794-x","volume":"11","author":"J Winkler","year":"2020","unstructured":"Winkler J, Abisoye-Ogunniyan A, Metcalf KJ, Werb Z (2020) Concepts of extracellular matrix remodelling in tumour progression and metastasis. Nat Commun 11:5120","journal-title":"Nat Commun"},{"key":"456_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19103028","author":"C Walker","year":"2018","unstructured":"Walker C, Mojares E, Del R\u00edo Hern\u00e1ndez A (2018) Role of extracellular matrix in development and cancer progression. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms19103028","journal-title":"Int J Mol Sci"},{"key":"456_CR28","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.15252\/embr.201439246","volume":"15","author":"MW Pickup","year":"2014","unstructured":"Pickup MW, Mouw JK, Weaver VM (2014) The extracellular matrix modulates the hallmarks of cancer. EMBO Rep 15:1243\u20131253","journal-title":"EMBO Rep"},{"key":"456_CR29","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1146\/annurev.cellbio.22.010305.104315","volume":"22","author":"CM Nelson","year":"2006","unstructured":"Nelson CM, Bissell MJ (2006) Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer. Annu Rev Cell Dev Biol 22:287\u2013309","journal-title":"Annu Rev Cell Dev Biol"},{"key":"456_CR30","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1083\/jcb.201102147","volume":"196","author":"P Lu","year":"2012","unstructured":"Lu P, Weaver VM, Werb Z (2012) The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol 196:395\u2013406","journal-title":"J Cell Biol"},{"key":"456_CR31","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1126\/science.1176009","volume":"326","author":"RO Hynes","year":"2009","unstructured":"Hynes RO (2009) The extracellular matrix: not just pretty fibrils. Science 326:1216\u20131219","journal-title":"Science"},{"key":"456_CR32","doi-asserted-by":"publisher","first-page":"4195","DOI":"10.1242\/jcs.023820","volume":"123","author":"C Frantz","year":"2010","unstructured":"Frantz C, Stewart KM, Weaver VM (2010) The extracellular matrix at a glance. J Cell Sci 123:4195\u20134200","journal-title":"J Cell Sci"},{"key":"456_CR33","doi-asserted-by":"publisher","first-page":"16079","DOI":"10.1073\/pnas.1306556110","volume":"110","author":"SY Chuang","year":"2013","unstructured":"Chuang SY, Yang CH, Chou CC, Chiang YP, Chuang TH, Hsu LC (2013) TLR-induced PAI-2 expression suppresses IL-1\u03b2 processing via increasing autophagy and NLRP3 degradation. Proc Natl Acad Sci U S A 110:16079\u201316084","journal-title":"Proc Natl Acad Sci U S A"},{"key":"456_CR34","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.cell.2007.07.009","volume":"130","author":"FR Greten","year":"2007","unstructured":"Greten FR, Arkan MC, Bollrath J et al (2007) NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta. Cell 130:918\u2013931","journal-title":"Cell"},{"key":"456_CR35","doi-asserted-by":"publisher","first-page":"3086","DOI":"10.1016\/j.cub.2021.04.078","volume":"31","author":"K Kozawa","year":"2021","unstructured":"Kozawa K, Sekai M, Ohba K et al (2021) The CD44\/COL17A1 pathway promotes the formation of multilayered, transformed epithelia. Curr Biol 31:3086-3097.e3087","journal-title":"Curr Biol"},{"key":"456_CR36","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.clinbiochem.2021.03.003","volume":"92","author":"HY Liao","year":"2021","unstructured":"Liao HY, Da CM, Liao B, Zhang HH (2021) Roles of matrix metalloproteinase-7 (MMP-7) in cancer. Clin Biochem 92:9\u201318","journal-title":"Clin Biochem"},{"key":"456_CR37","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.clon.2014.02.004","volume":"26","author":"A Shibata","year":"2014","unstructured":"Shibata A, Jeggo PA (2014) DNA double-strand break repair in a cellular context. Clin Oncol (R Coll Radiol) 26:243\u2013249","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"456_CR38","first-page":"51","volume":"803\u2013805","author":"A Shibata","year":"2017","unstructured":"Shibata A (2017) Regulation of repair pathway choice at two-ended DNA double-strand breaks. Mutat Res 803\u2013805:51\u201355","journal-title":"Mutat Res"},{"key":"456_CR39","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1111\/cas.14197","volume":"110","author":"H Sato","year":"2019","unstructured":"Sato H, Jeggo PA, Shibata A (2019) Regulation of programmed death-ligand 1 expression in response to DNA damage in cancer cells: implications for precision medicine. Cancer Sci 110:3415\u20133423","journal-title":"Cancer Sci"},{"key":"456_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/genes12091370","author":"A Shibata","year":"2021","unstructured":"Shibata A, Jeggo PA (2021) ATM\u2019s role in the repair of DNA double-strand breaks. Genes. https:\/\/doi.org\/10.3390\/genes12091370","journal-title":"Genes"},{"issue":"1","key":"456_CR41","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41392-022-01102-y","volume":"7","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Liu X, Chen D, Yu J (2022) Radiotherapy combined with immunotherapy: the dawn of cancer treatment. Signal Transduct Target Ther 7(1):258","journal-title":"Signal Transduct Target Ther"},{"key":"456_CR42","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41577-022-00751-y","volume":"23","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Simon M, Seluanov A, Gorbunova V (2023) DNA damage and repair in age-related inflammation. Nat Rev Immunol 23:75\u201389","journal-title":"Nat Rev Immunol"},{"key":"456_CR43","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41575-020-0273-0","volume":"17","author":"A Salas","year":"2020","unstructured":"Salas A, Hernandez-Rocha C, Duijvestein M et al (2020) JAK-STAT pathway targeting for the treatment of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 17:323\u2013337","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"456_CR44","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/s41577-020-0288-3","volume":"20","author":"J Rehwinkel","year":"2020","unstructured":"Rehwinkel J, Gack MU (2020) RIG-I-like receptors: their regulation and roles in RNA sensing. Nat Rev Immunol 20:537\u2013551","journal-title":"Nat Rev Immunol"},{"key":"456_CR45","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun SC (2017) NF-kappaB signaling in inflammation. Signal Transduct Target Ther 2:17023","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"456_CR46","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.clon.2014.02.004","volume":"26","author":"A Shibata","year":"2014","unstructured":"Shibata A, Jeggo PA (2014) DNA double-strand break repair in a cellular context. Clin Oncol (R Coll Radiol) 26(5):243\u2013249","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"456_CR47","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ccr.2013.01.026","volume":"23","author":"S Takeishi","year":"2013","unstructured":"Takeishi S, Matsumoto A, Onoyama I, Naka K, Hirao A, Nakayama KI (2013) Ablation of Fbxw7 eliminates leukemia-initiating cells by preventing quiescence. Cancer Cell 23:347\u2013361","journal-title":"Cancer Cell"},{"key":"456_CR48","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.molcel.2015.10.040","volume":"60","author":"MJ O'Connor","year":"2015","unstructured":"O\u2019Connor MJ (2015) Targeting the DNA damage response in cancer. Mol Cell 60:547\u2013560","journal-title":"Mol Cell"},{"key":"456_CR49","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1111\/cas.16117","volume":"115","author":"T Higa","year":"2024","unstructured":"Higa T, Nakayama KI (2024) Cell cycle heterogeneity and plasticity of colorectal cancer stem cells. Cancer Sci 115:1370\u20131377","journal-title":"Cancer Sci"}],"container-title":["Medical Molecular Morphology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00795-026-00456-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00795-026-00456-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00795-026-00456-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T08:02:14Z","timestamp":1780128134000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00795-026-00456-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,11]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["456"],"URL":"https:\/\/doi.org\/10.1007\/s00795-026-00456-4","relation":{},"ISSN":["1860-1480","1860-1499"],"issn-type":[{"value":"1860-1480","type":"print"},{"value":"1860-1499","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,11]]},"assertion":[{"value":"5 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}